在类风湿性关节炎中使用常规抗风湿药物或葡萄糖皮质类药物的单一治疗:网络元分析
Louise S Guski1, Gesche Jürgens1, Hugo Pedder2
1Clinical Pharmacology Unit, Zealand University Hospital, Roskilde, Denmark.
JAMA network open
|October 6, 2023
概括
甲托雷克萨特是治疗类风湿性关节炎的主要常规合成修饰疾病的抗风湿药物,与安慰剂相比,柔软关节的数量显著改善. 其他药物也表现出类似或低于甲醇的疗效.
科学领域:
- 类风湿病学 类风湿病学
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 类风湿性关节炎 (RA) 是一种慢性自身免疫性疾病,需要有效的疾病修饰性抗风湿药物 (DMARDs).
- 传统的合成DMARDs (csDMARDs) 和葡萄糖皮质激素是常见的治疗选择,但比较有效性数据是复杂的.
- 这项研究解决了对这些治疗方法进行比较的综合网络元分析的需求.
研究的目的:
- 进行第一个网络元分析,评估各种csDMARDs和风湿性关节炎中的葡萄皮质类药物的结果.
- 根据关节计数和炎症标志物,比较这些治疗方法的临床疗效.
- 建立RA管理治疗有效性的层次结构.
主要方法:
- 在多个数据库 (MEDLINE,Embase,Cochrane Central,ClinicalTrials.gov) 进行系统搜索,截至2022年9月.
- 包括132个随机对照试验,涉及13,260名RA患者,比较csDMARDs,葡萄糖皮质激素或安慰剂.
- 网络元分析使用随机效应模型,评估招标联合计数作为主要结果.
主要成果:
- 与安慰剂相比,口服甲铁酸显著减少了柔软关节数 (-5.18个关节).
- 葡萄皮质皮质类药物和大多数其他csDMARDs与甲醇相比,在柔软的关节细胞数方面显示出类似或不那么有利的结果.
- 分析了132项试验中的275个治疗组中的29项干预措施的数据.
结论:
- 这些发现支持甲状腺素作为类风湿性关节炎的主要参考csDMARD的既定作用.
- 与安慰剂相比,甲索在减少关节症状方面具有更高的疗效.
- 这个网络的元分析为RA治疗决策提供了有价值的比较有效性数据.
相关概念视频
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
141
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
141
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
178
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
178
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
154
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
154
01:11Genome-wide Association Studies-GWAS
13.5K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.5K
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
281
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
281
01:21Rheumatic Heart Disease III: Medical Management
11
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
11